The Venereal Disease Research Laboratory (VDRL) test is a non-treponemal test used to screen for syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. It detects the presence of antibodies (specifically, anti-cardiolipin antibodies) produced in response to the infection.

High-Risk Groups:

• Individuals with multiple sexual partners.
• Men who have sex with men (MSM).
• Individuals with a history of STIs.
• Pregnant women (routine screening recommended).
• Persons living with HIV.

Low-Risk Groups:

• Individuals in monogamous relationships.
• Those practicing safe sex.

The VDRL test result is typically reported as:

• Negative: No significant antibodies detected.
• Positive: Indicates the presence of antibodies, which may require further testing (e.g., treponemal tests like the FTA-ABS).

Interpretation

1. Negative Result: No evidence of syphilis.

2. Positive Result: Further investigation is needed, as a positive VDRL can also indicate other conditions (e.g., certain autoimmune diseases, infections).

   • Titer Levels: If positive, the result may include a titer (e.g., 1:1, 1:4), indicating the concentration of antibodies. Higher titers suggest active disease or recent infection.

3. False Positives: Conditions such as malaria, pregnancy, and certain autoimmune disorders can cause false-positive results.

Serum: Blood is drawn from a vein and serum is separated for testing.